References - AMA Manual of Style

Subscriber Login

Forgotten your password?

Show Summary Details
Page of



Study Design and Statistics

Margaret A. Winker

and Stephen J. Lurie

Page of

PRINTED FROM AMA MANUAL OF STYLE ONLINE ( © American Medical Association, 2009. All Rights Reserved. Under the terms of the license agreement, an individual user may print out a PDF of a single chapter of a title in AMA Manual of Style Online for personal use (for details see Privacy Policy). 

Subscriber: null; date: 27 August 2016


1. Partington A, ed. The Oxford Dictionary of Quotations. 4th ed. Oxford, England: Oxford University Press; 1992.Find this resource:

    2. Haynes RB, Mulrow CD, Huth EJ, Altman DG, Gardner MJ. More informative abstracts revisited. Ann Intern Med. 1990;113(1):69-76.Find this resource:

    3. Guyatt G, Rennie D, eds. Users’ Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice Chicago, IL: AMA Press; 2002:7.Find this resource:

      4. Moher D, Schulz KF, Altman D; for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA. 2001;285(15):1987-1991.Find this resource:

      5. Campbell MJ. Extending CONSORT to include cluster trials. BMJ. 2004;328(7441):654-655.Find this resource:

      6. Weijer C, Shapiro SH, Cranley Glass K. For and against: clinical equipoise and not the uncertainty principle is the moral underpinning of the randomised controlled trial. BMJ. 2000;321(72263):756-758.Find this resource:

      7. Hellman D. Evidence, belief, and action: the failure of equipoise to resolve the ethical tension in the randomized clinical trial. J Law Med Ethics. 2002;30(3):375-380.Find this resource:

      8. Meinert CL. Clinical Trials Dictionary: Terminology and Usage Recommendations. Baltimore, MD: Harbor Duvall Graphics; 1996.Find this resource:

        9. DeAngelis CD, Drazen JM, Frizelle FA, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. JAMA. 2004;292(11):1363-1364.Find this resource:

        10. Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJW; for the CONSORT Group. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA. 2006;295(10):1152-1160.Find this resource:

        11. D. Moher D, Schulz KF, Altman DG, for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med. 2001;134(8):657-662.Find this resource:

        12. Rossouw JE, Anderson GL, Prentice RL, et al; Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333.Find this resource:

        13. Moher D, Olkin I. Meta-analysis of randomized controlled clinical trials: a concern for standards. JAMA. 1995;274(24):1962-1964.Find this resource:

        14. Bailar JC III. The practice of meta-analysis. J Clin Epidemiol. 1995;48(1):149-157.Find this resource:

        15. Shapiro S. Meta-analysis/shmeta-analysis. Am J Epidemiol. 1994;140(9):771-778.Find this resource:

        16. Pettiti DB. Of babies and bathwater. Am J Epidemiol. 1994;140(9):779-782.Find this resource:

        17. Greenland S. Can meta-analysis be salvaged? Am J Epidemiol. 1994;140(9):783-787.Find this resource:

        18. Chalmers TC, Lau J. Meta-analytic stimulus for changes in clinical trials. Stat Methods Med Res. 1993;2(2):161-172.Find this resource:

        19. Jadad AR, McQuay HJ. Meta-analyses to evaluate analgesic interventions: a systematic qualitative review of their methodology. J Clin Epidemiol. 1996;49(2):235-243.Find this resource:

        20. Sampson M, Barrowman NJ, Moher D, et al. Should meta-analysts search EMBASE in addition to MEDLINE? J Clin Epidemiol. 2003;56(10):943-955.Find this resource:

        21. Easterbrook PJ, Berlin J, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet. 1991;337(8746):867-872.Find this resource:

        22. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ. 1994;309(6964):1286-1291.Find this resource:

        23. Gerbarg ZB, Horwitz RI. Resolving conflicting clinical trials: guidelines for meta-analysis. J Clin Epidemiol. 1988;41(5):502-509.Find this resource:

        24. Thompson SG. Why sources of heterogeneity in meta-analysis should be investigated. BMJ. 1994;309(6965):1351-1355.Find this resource:

        25. Bero L, Rennie D. The Cochrane Collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care. JAMA. 1995;274(24):1935-1938.Find this resource:

        26. Udvarhelyi IS, Colditz GA, Rai A, Epstein AM. Cost-effectiveness and cost-benefit analyses in the medical literature: are the methods being used correctly? Ann Intern Med. 1992;116(3):238-244.Find this resource:

        27. Kassirer JP, Angell M. The Journal’s policy on cost-effectiveness analyses. N Engl J Med. 1994;331(10):669-670.Find this resource:

        28. Hill SR, Mitchell AS, Henry DA. Problems with the interpretation of pharmacoeconomic analyses: a review of submissions to the Australian Pharmaceutical Benefits Scheme. JAMA. 2000;283(16):2116-2121.Find this resource:

        29. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role of cost-effectiveness analysis in health and medicine. JAMA. 1996;276(14):1172-1177.Find this resource:

        30. Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analyses: Panel on Cost-effectiveness in Health and Medicine. JAMA. 1996;276(16):1339-1341.Find this resource:

        31. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ. 1996;313(7052):275-283.Find this resource:

        32. Drummond MF, Richardson WS, O'Brien BJ, Levine M, Heyland D; for the Evidence-Based Medicine Working Group. Users’ guides to the medical literature: how to use an article on economic analyses of clinical practice, A: are the results of the study valid? JAMA. 1996;277(19):1552-1557.Find this resource:

          33. Saha S, Hoerger TJ, Pignone MP, Teutsch SM, Helfand M, Mandelblatt JS; Cost Work Group, Third US Preventive Services Task Force. The art and science of incorporating cost effectiveness into evidence-based recommendations for clinical preventive services. Am J Prev Med. 2001;20(3)(suppl):36-43.Find this resource:

          34. Mark DM. Visualizing cost-effectiveness analysis. JAMA. 2002;287(18):2428-2429.Find this resource:

          35. Bossuyt PM, Reitsma JB, Bruns DE, et al; for the STARD group. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD Initiative. Clin Radiol. 2003;58(8):575-580.Find this resource:

          36. American Association for Public Opinion Research. Standard definitions: final dispositions of case codes and outcome rates for surveys. Accessed August 1, 2006.

          37. Bailar JC, Mosteller F. Medical Uses of Statistics. 2nd ed. Boston, MA: NEJM Books; 1992.Find this resource:

            38. Marriott FHC. A Dictionary of Statistical Terms. 5th ed. Essex, England: Longman Scientific & Technical; 1990.Find this resource:

              39. Glantz SA. Primer of Biostatistics. 2nd ed. New York, NY: McGraw-Hill Book Co Inc; 1981.Find this resource:

                40. Reigelman RK, Hirsch RP. Studying a Study and Testing a Test. 2nd ed. Boston, MA: Little Brown & Co Inc; 1989.Find this resource:

                  41. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307-310.Find this resource:

                  42. Last JM. A Dictionary of Epidemiology. 3rd ed. New York, NY: Oxford University Press; 1995.Find this resource:

                    43. Lang TA, Secic M. Reporting Statistical Information in Medicine: Annotated Guide for Authors, Editors, and Reviewers. Philadelphia, PA: American College of Physicians; 1997.Find this resource:

                      44. Everitt BS. The Cambridge Dictionary of Statistics in the Medical Sciences. Cambridge, England: Cambridge University Press; 1995.Find this resource:

                        45. Homedes N. The disability-adjusted life year (DALY) definition, measurement and potential use. Accessed April 30, 2005.

                        46. Ingelfinger JA, Mosteller F, Thibodeau LA, Ware JH. Biostatistics in Clinical Medicine. 3rd ed. New York, NY: McGraw-Hill Book Co Inc; 1994.Find this resource:

                          47. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons Inc; 1989.Find this resource:

                            48. Everitt BS. Statistical Methods for Medical Investigations. 2nd ed. New York, NY: John Wiley & Sons Inc; 1994.Find this resource:

                              49. Colton T. Statistics in Medicine. Boston, MA: Little Brown & Co Inc; 1974.Find this resource:

                                50. Guyatt G, Sackett D, Taylor DW, et al. Determining optimal therapy: randomized trial in individual patients. N Engl J Med. 1986;314(14):889-892.Find this resource:

                                51. Zhang J, Yu KF. What’s the relative risk? a method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690-1691.Find this resource:

                                52. Scherer RW, Dickersin K, Langenberg P. Full publication of results initially presented as abstracts: a meta-analysis. JAMA. 1994;272(2):158-162.Find this resource:

                                53. Pope C, Mays N. Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research. BMJ. 1995;311(6996):42-45.Find this resource:

                                54. Brown GW. Standard deviation, standard error: which “standard” should we use? AJDC. 1982;136(10):937-941.Find this resource:

                                55. Geng D. Conventions in statistical symbols and abbreviations. CBE Views. 1992; 15(5):95-96.Find this resource:

                                  Previous | Next